MicroRNA-98 can serve as a diagnostic marker for congenital heart disease-associated pulmonary artery hypertension  

作　　者：Yao-Zhong Zhang Gang Li Dao-Le Yan Ying-Long Liu 

机构地区：[1]Pediatric Cardiac Center,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart Lung and Blood Vessel Diseases,Beijing 100029,China

出　　处：《Chinese Medical Journal》2020年第24期3007-3009,共3页中华医学杂志（英文版）

摘　　要：Congenital heart disease(CHD)has become the leading mortal cause for an infant from congenital abnormalities.Pulmonary artery hypertension(PAH)is one of the complications of CHD.[1]It has also been reported that upregulation of microRNA-98(miR-98)could mediate the suppression of cardiac hypertrophy,which implies that miR-98 might play an important role in CHD.[2]In this study,the clinical data from hospitalized patients were retrospectively analyzed to identify if there is any evidence of diagnosis of circulating miR-98 on CHD patients with PAH.

关 键 词：HYPERTENSION diagnosis ARTERY INFANT 

分 类 号：R725.4[医药卫生—儿科]